Beers David C
Known title: Chief Financial OfficerCIK: 0001869583
Associated companies
Transaction History
| CELU | ▲ Buy | Option Exercise | 1,025 | $0 | 4/13/2025 | View on chart |
| CELU | ▼ Sell | Tax Withholding | 360 | $590 | 4/13/2025 | View on chart |
| CELU | ▼ Sell | Tax Withholding | 4,396 | $9K | 2/17/2025 | View on chart |
| CELU | ▲ Buy | Option Exercise | 12,500 | $0 | 2/17/2025 | View on chart |
| CELU | ▼ Sell | Tax Withholding | 360 | $1K | 4/13/2024 | View on chart |
| CELU | ▼ Sell | Tax Withholding | 43,968 | $19K | 2/17/2024 | View on chart |
| CELU | ▼ Sell | Tax Withholding | 3,606 | $3K | 4/13/2023 | View on chart |
| CELU | ▲ Buy | Grant | 250,000 | — | 2/17/2023 | View on chart |
| CELU | ▲ Buy | Grant | 41,011 | — | 4/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Celularity Q1 2027 EPS Up, Announces Partner & Board Member
Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.
Celularity Q1 2027 EPS Up, Announces Partner & Board Member. Celularity posted a first‑quarter 2027 earnings per share of $0.02, up from a loss of $0.84 a year earlier, while sales fell to $3.85 million from $11.43 million. The company will open the Fontaine Vitale facility with its strategic partner and added Naveen Jain to its board. It also closed a $10 million private placement of senior secured convertible notes and warrants, part of a $28 million recapitalization plan.